These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 10669448)

  • 1. Regular review: tumour markers in malignancies.
    Lindblom A; Liljegren A
    BMJ; 2000 Feb; 320(7232):424-7. PubMed ID: 10669448
    [No Abstract]   [Full Text] [Related]  

  • 2. The diagnostic value of beta-catenin immunohistochemistry.
    Montgomery E; Folpe AL
    Adv Anat Pathol; 2005 Nov; 12(6):350-6. PubMed ID: 16330931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing breast biomarker status between routine immunohistochemistry and FISH studies and Oncotype DX testing, a study of 610 cases.
    Neely C; You S; Mendoza PM; Aneja R; Sahin AA; Li X
    Breast J; 2018 Nov; 24(6):889-893. PubMed ID: 30230095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring tissue-based biomarkers by immunochromatography coupled with reverse-phase lysate microarray.
    Romeo MJ; Wunderlich J; Ngo L; Rosenberg SA; Steinberg SM; Berman DM
    Clin Cancer Res; 2006 Apr; 12(8):2463-7. PubMed ID: 16638853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AMACR: an emerging diagnostic and prognostic tool in systemic malignancies.
    Kapoor S
    Int Urol Nephrol; 2013 Apr; 45(2):439-40. PubMed ID: 23392962
    [No Abstract]   [Full Text] [Related]  

  • 6. Pathology and the Internet.
    Wheeler D
    Adv Anat Pathol; 2003 Jul; 10(4):234-5. PubMed ID: 12826830
    [No Abstract]   [Full Text] [Related]  

  • 7. Equivalency of RT-PCR and immunohistochemistry: fact or factoid.
    Badve S
    Breast Cancer Res Treat; 2009 Jul; 116(1):145-7. PubMed ID: 18787946
    [No Abstract]   [Full Text] [Related]  

  • 8. Promises and limitations of biomarkers.
    Ransohoff DF
    Recent Results Cancer Res; 2009; 181():55-9. PubMed ID: 19213557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of routine histology, immunohistochemistry, reverse transcriptase polymerase chain reaction, and fluorescence in situ hybridization in diagnosis of Ewing family of tumors.
    Jambhekar NA; Bagwan IN; Ghule P; Shet TM; Chinoy RF; Agarwal S; Joshi R; Amare Kadam PS
    Arch Pathol Lab Med; 2006 Dec; 130(12):1813-8. PubMed ID: 17149955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The future of molecular markers in cancer: towards a tailored treatment].
    Gascón P
    Med Clin (Barc); 2009 Apr; 132(14):549-50. PubMed ID: 19368936
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of Molecular and Immunohistochemical Adjunct Modalities in the Diagnosis of Soft Tissue Neoplasms.
    Mourtzoukou D; Fisher C; Thway K
    Int J Surg Pathol; 2015 Dec; 23(8):601-8. PubMed ID: 26310271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Judging new markers by their ability to improve predictive accuracy.
    Kattan MW
    J Natl Cancer Inst; 2003 May; 95(9):634-5. PubMed ID: 12734304
    [No Abstract]   [Full Text] [Related]  

  • 13. Improved indicators for assessing the reliability of detection and quantification by kinetic PCR.
    Soong R; Ladányi A
    Clin Chem; 2003 Jun; 49(6 Pt 1):973-6. PubMed ID: 12766001
    [No Abstract]   [Full Text] [Related]  

  • 14. Current status of CD44 variant isoforms as cancer diagnostic markers.
    Goodison S; Tarin D
    Histopathology; 1998 Jan; 32(1):1-6. PubMed ID: 9522209
    [No Abstract]   [Full Text] [Related]  

  • 15. Urinary Biomarkers In Bladder Cancer.
    Costantini M; Gallo G; Attolini G
    Methods Mol Biol; 2021; 2292():121-131. PubMed ID: 33651357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic biomarkers for renal cell carcinoma: selection using novel bioinformatics systems for microarray data analysis.
    Osunkoya AO; Yin-Goen Q; Phan JH; Moffitt RA; Stokes TH; Wang MD; Young AN
    Hum Pathol; 2009 Dec; 40(12):1671-8. PubMed ID: 19695674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electron microscopy in tumour diagnosis: continuing to complement other diagnostic techniques.
    Eyden B
    Histopathology; 1999 Aug; 35(2):102-8. PubMed ID: 10460653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-invasive methods of bladder cancer detection.
    Little B
    Int Urol Nephrol; 2003; 35(3):331-43. PubMed ID: 15160535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunodiagnosis of childhood malignancies.
    Parham DM; Holt H
    Mol Biotechnol; 1999 Sep; 12(2):207-16. PubMed ID: 10596376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating microRNAs: potential biomarkers for common malignancies.
    Khoury S; Tran N
    Biomark Med; 2015; 9(2):131-51. PubMed ID: 25689901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.